You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Claims for Patent: 10,400,211

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,400,211

Title:	Cell composition for tissue regeneration
Abstract:	A method of extracting human progenitor cells from perivascular tissue of human umbilical cord. The extracted cells are then co-cultured with nonhematopoietic stem cells and are useful to grow and repair human tissues including bone. Also included are related methods and compositions related thereto.
Inventor(s):	Rudd; Donnie (Sugar Land, TX), Contreras; Ramiro (Tustin, CA)
Assignee:
Application Number:	15/466,754
Patent Claims:	1. A method of obtaining human progenitor cells comprising the steps of: providing a human umbilical cord with vasculature; washing the umbilical cord with vasculature; isolating perivascular tissue proximal to the vasculature; digesting the perivascular tissue and thereby obtaining a soluble perivascular fraction; isolating human progenitor cells from the perivascular fraction; and co-culturing the human progenitor cells with non-hematopoietic stem cells. 2. The method of claim 1 further comprising isolating the perivascular tissue from a zone extending to about 3 mm from an external wall of the umbilical cord vasculature. 3. The method of claim 2 further comprising excising the perivascular tissue from the umbilical cord by pulling the vasculature fraction and the surrounding perivascular fraction away from the surrounding cord tissue. 4. The method of claim 3 further comprising tying the ends of vessels in the vasculature fraction and suspending the vessels, thereby obtaining a perivascular fraction free from cord blood cells, umbilical cord epithelial cells, vessel endothelial cells and vessel smooth muscle cells. 5. The method of claim 1 further comprising digesting the perivascular fraction with collagenase. 6. The method of claim 1 wherein the co-culturing is accomplished in a two-dimensional system. 7. The method according to claim 1 where the non-hematopoietic stem cells stem cells are selected from the group consisting of multipotent stromal cells, human mesenchymal stem cells, tissue specific stem cells. 8. The method according to claim 7 where the tissue specific stem cells are selected from the group consisting of liver stem cells, cardiac stem cells, neural stem cells, skin stem cells, intestinal stem cells, pancreatic stem cells, airway basal stem cells, epithelial stem cells, bile tree stem cells, dental stem cells, skeletal muscle stem cells, mammary stem cells, olfactory adult stem cells, neural crest stem cells, satellite cells, cardiac progenitor cells, endothelial progenitors, osteoprogenitor cells, liver progenitors, pancreatic progenitors, human renal progenitors and neuronal progenitor cells. 9. The method according to claim 1 where the non-hematopoietic stem cells are selected from the group consisting of adipose-derived stromal cells and adipose-derived mesenchymal stem cells. 10. The method according to claim 1 wherein the fraction of digested perivascular tissue is co-cultured with non-hematopoietic stem cells and non-hematopoietic progenitors cells. 11. A method of obtaining tissue regenerating cells comprising isolating a human progenitor cell from the perivascular tissue of human umbilical cord, and co-culturing said cells with non-hematopoietic stem cells. 12. A method for obtaining human progenitor cells comprising the steps of: providing a human umbilical cord with vasculature; washing the human umbilical cord with vasculature; isolating perivascular tissue proximal to the vasculature; and digesting the perivascular tissue so that human progenitor cell fractions are obtained; co-culturing at least a fraction of the digested perivascular tissue with non-hematopoietic stem cells to produce an expanded composition including human progenitor cells. 13. The method according to claim 12 where the non-hematopoietic are selected from the group consisting of multipotent stromal cells, human mesenchymal stem cells, tissue specific stem cells. 14. The method according to claim 13 where the tissue specific stem cells are selected from the group consisting of liver stem cells, cardiac stem cells, neural stem cells, skin stem cells, intestinal stem cells, pancreatic stem cells, airway basal stem cells, epithelial stem cells, bile tree stem cells, dental stem cells, skeletal muscle stem cells, mammary stem cells, olfactory adult stem cells, neural crest stem cells, satellite cells, cardiac progenitor cells, endothelial progenitors, osteoprogenitor cells, liver progenitors, pancreatic progenitors, human renal progenitors and neuronal progenitor cells. 15. The method according to claim 12 where the non-hematopoietic stem cells are selected from the group consisting of adipose-derived stromal cells and adipose-derived mesenchymal stem cells. 16. The method according to claim 12 wherein the fraction of digested perivascular tissue is co-cultured with non-hematopoietic stem cells and non-hematopoietic progenitors cells.

Details for Patent 10,400,211

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965	⤷ Try a Trial	2034-04-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.